Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: RETRACTED ARTICLE: LncRNA SOX21-AS1 accelerates endometrial carcinoma progression through the miR-7-5p/RAF1 pathway

Fig. 3

MiR-7-5p has a binding site in SOX21-AS1. A The predicted binding sequence of miR-7-5p and SOX21-AS1. B Luciferase reporter assay. C RIP assay. D The levels of miR-7-5p in HEC-1A and Ishikawa cells transfected with sh-SOX21-AS1 and sh-NC. E The levels of miR-7-5p in EC tissues and cells. F Correlation analysis of miR-7-5p and SOX21-AS1 levels in EC tissues. *P< 0.05, **P < 0.01, and ***P < 0.001

Back to article page